U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9891198911Effects of Dobutamine on Microcirculation, Regional and Peripheral Perfusion in Septic Shock PatientsCompletedNo Results AvailableSeptic ShockDrug: Dobutamine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01271153
9891298912High Dose Insulin Therapy to Improve Liver FunctionActive, not recruitingNo Results AvailableHepatitis C VirusDrug: Insulinhttps://ClinicalTrials.gov/show/NCT01271140
9891398913Screening for Coronary Artery Disease After Mediastinal IrradiationCompletedNo Results AvailableRadiation Therapy|Coronary Artery Disease|Hodgkin LymphomaRadiation: CT coronary angiographyhttps://ClinicalTrials.gov/show/NCT01271127
9891498914Hypertonic Saline and Terlipressin for Sepsis-associated HypotensionTerminatedNo Results AvailableSeptic Shock|Sepsis-associated HypotensionDrug: Hypertonic Saline and Terlipressin|Drug: Normal saline and norepinephrinehttps://ClinicalTrials.gov/show/NCT01271114
9891598915The Efficacy and Safety of Anticoagulation in Chinese Patients With Non-ST Segment Elevation Acute Coronary SyndromeRecruitingNo Results AvailableAcute Coronary Syndromehttps://ClinicalTrials.gov/show/NCT01271101
9891698916Protective Effect of N-acetylcysteine Against From OtotoxicityCompletedNo Results AvailableHearing Loss, ExtremeDrug: N-acetylcysteinehttps://ClinicalTrials.gov/show/NCT01271088
9891798917Bilastine Updosing - Characterization of Underlying MechanismsCompletedNo Results AvailableCold Contact UrticariaDrug: Bilastine|Drug: Bilastinehttps://ClinicalTrials.gov/show/NCT01271075
9891898918Restoration of Beta Cell Function and Cardiovascular Parameters in Relation to Adipoinsular and Enteroinsular Axes After Gastric Bypass SurgeryCompletedNo Results AvailableDiabetes Mellitus, Type 2|Bariatric Surgery CandidateProcedure: gastric bypass surgery|Procedure: abdominal surgery|Behavioral: very low caloric diethttps://ClinicalTrials.gov/show/NCT01271062
9891998919An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for HelminthsTerminatedNo Results AvailableHelminthiasisOther: Novel Food Product|Other: Control Food Producthttps://ClinicalTrials.gov/show/NCT01271049
9892098920Safety Study of a Sensitive Sensual Touch and Personal LubricantCompletedHas ResultsInadequate LubricationDevice: Formula PD-F-7716https://ClinicalTrials.gov/show/NCT01271036
9892198921Inpatient Evaluation of an Automated Closed-Loop Control-to-Range SystemCompletedNo Results AvailableType 1 DiabetesDevice: Control-to-Range Automated Insulin Management Systemhttps://ClinicalTrials.gov/show/NCT01271023
9892298922A Study of MabThera (Rituximab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic StatusActive, not recruitingNo Results AvailableLymphocytic Leukemia, ChronicDrug: cyclophosphamide|Drug: fludarabine|Drug: rituximab [MabThera]https://ClinicalTrials.gov/show/NCT01271010
9892398923Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA PatientsCompletedNo Results AvailableRheumatoid ArthritisBiological: Etanercept|Biological: Etanercepthttps://ClinicalTrials.gov/show/NCT01270997
9892498924Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy SubjectsCompletedNo Results AvailableChronic Myeloid Leukemia|Gastrointestinal Stromal TumorsDrug: Luckyvec 400mg film coated tablet|Drug: Glivec 100mg film coated tablethttps://ClinicalTrials.gov/show/NCT01270984
9892598925Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the ToenailCompletedHas ResultsOnychomycosis of ToenailsDrug: AN2690 Topical Solution, 5%|Drug: Solution Vehiclehttps://ClinicalTrials.gov/show/NCT01270971
9892698926A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic RhinitisCompletedHas ResultsRhinitis, Allergic, PerennialDrug: Avamys aqueous nasal spray 110mcghttps://ClinicalTrials.gov/show/NCT01270958
9892798927Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.CompletedNo Results AvailablePatients Undergoing Repeat Peripheral Artery RevascularizationDrug: CV-18C3|Procedure: Standard of Carehttps://ClinicalTrials.gov/show/NCT01270945
9892898928Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure PatientsRecruitingNo Results AvailableRenal Failure|Multiple MyelomaDrug: Lenalidomide and Dexamethasonehttps://ClinicalTrials.gov/show/NCT01270932
9892998929A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair DeviceTerminatedHas ResultsKnee Meniscus TearDevice: BioDuct Meniscal Repair Devicehttps://ClinicalTrials.gov/show/NCT01270919
9893098930Safety of CHIR-258 (TKI258) in Advanced Solid TumorsTerminatedNo Results AvailableNeoplasms|Cancer|TumorsDrug: CHIR-258 (TKI258)https://ClinicalTrials.gov/show/NCT01270906
9893198931Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)WithdrawnNo Results AvailableGastrointestinal CancerDrug: Nilotinibhttps://ClinicalTrials.gov/show/NCT01270893
9893298932Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyCompletedHas ResultsAdenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate CancerDrug: Hsp90 inhibitor STA-9090|Other: laboratory biomarker analysis|Genetic: polymerase chain reaction|Other: enzyme-linked immunosorbent assay|Genetic: RNA analysis|Other: spectrophotometry|Genetic: reverse transcriptase-polymerase chain reaction|Genetic: gene expression analysishttps://ClinicalTrials.gov/show/NCT01270880
9893398933Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic StrokeCompletedHas ResultsIschemic StrokeDevice: Mechanical Thrombectomyhttps://ClinicalTrials.gov/show/NCT01270867
9893498934Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma PatientsCompletedNo Results AvailableWounds and Injuries|Multiple Trauma|Disorder of Fluid BalanceOther: Plasmalyte A|Other: Normal Salinehttps://ClinicalTrials.gov/show/NCT01270854
9893598935Normalization of Morning Testosterone Levels in Men With Secondary HypogonadismCompletedHas ResultsSecondary HypogonadismDrug: Placebo|Drug: topical testosterone|Drug: Androxalhttps://ClinicalTrials.gov/show/NCT01270841
9893698936Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic NeuralgiaCompletedNo Results AvailablePost Herpetic NeuralgiaDrug: Pregabalin|Drug: placebohttps://ClinicalTrials.gov/show/NCT01270828
9893798937An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Pregabalin controlled release, 330 mg, 400 to 500 calories|Drug: Pregabalin controlled release, 330 mg, 600 to 750 calories|Drug: Pregabalin controlled release, 330 mg, 800 to 1000 calories|Drug: Pregabalin immediate release, 300 mghttps://ClinicalTrials.gov/show/NCT01270815
9893898938Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected PatientsCompletedHas ResultsHIVDrug: Tenofovir/emtricitabine|Drug: Tenofovir/emtricitabine/efavirenz|Drug: Raltegravirhttps://ClinicalTrials.gov/show/NCT01270802
9893998939LIraglutide and Beta-cell RepAir (LIBRA) StudyCompletedNo Results AvailableType 2 DiabetesDrug: Liraglutide|Drug: placebohttps://ClinicalTrials.gov/show/NCT01270789
9894098940Efficacy Study Comparing 2% Chlorhexidine in 70% Isopropyl Alcohol Versus 2% Aqueous ChlorhexidineRecruitingNo Results AvailableAnti-infecting Agents, LocalDrug: 2% aqueous chlorhexidine|Drug: 2% Chlorhexidine 70% isopropyl alcoholhttps://ClinicalTrials.gov/show/NCT01270776

* Görseller ve İçerik tekif hakkına sahip olabilir